{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:07:19Z","timestamp":1784552839731,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG059988"],"award-info":[{"award-number":["P30AG059988"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00192-025-06441-2","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T13:53:08Z","timestamp":1766497988000},"page":"2027-2033","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline Anticholinergic Medication Burden in Patients with Overactive Bladder"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0644-1459","authenticated-orcid":false,"given":"Morgan","family":"Cheeks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Andebrhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Lancki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Emi","family":"Bretschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"1","key":"6441_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11884-16-0344-9","volume":"11","author":"WS Reynolds","year":"2016","unstructured":"Reynolds WS, Fowke J, Dmochowski R. The burden of overactive bladder on US Public Health. Curr Bladder Dysfunct Rep. 2016;11(1):8\u201313. https:\/\/doi.org\/10.1007\/s11884-16-0344-9.","journal-title":"Curr Bladder Dysfunct Rep"},{"issue":"5","key":"6441_CR2","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.urology.2010.08.039","volume":"77","author":"KS Coyne","year":"2011","unstructured":"Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology. 2011;77(5):1081\u20137. https:\/\/doi.org\/10.1016\/j.urology.2010.08.039.","journal-title":"Urology"},{"issue":"12","key":"6441_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.4140\/TCP.n.2014.823","volume":"29","author":"R Bragg","year":"2014","unstructured":"Bragg R, Hebel D, Vouri SM, Pitlick JM. Mirabegron: a beta-3 agonist for overactive bladder. Consult Pharm. 2014;29(12):823\u201337. https:\/\/doi.org\/10.4140\/TCP.n.2014.823.","journal-title":"Consult Pharm"},{"issue":"1","key":"6441_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/bju.15040","volume":"126","author":"B Welk","year":"2020","unstructured":"Welk B, McArthur E. Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study. BJU Int. 2020;126(1):183\u201390. https:\/\/doi.org\/10.1111\/bju.15040.","journal-title":"BJU Int"},{"issue":"1","key":"6441_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/nau.24536","volume":"40","author":"RR Dmochowski","year":"2021","unstructured":"Dmochowski RR, Thai S, Iglay K, Enemchukwu E, Tee S, Varano S, et al. Increased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysis. Neurourol Urodyn. 2021;40(1):28\u201337. https:\/\/doi.org\/10.1002\/nau.24536.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"6441_CR6","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.euf.2021.10.009","volume":"8","author":"R Matta","year":"2022","unstructured":"Matta R, Gomes T, Juurlink D, Jarvi K, Herschorn S, Nam RK. Receipt of overactive bladder drugs and incident dementia: a population-based case-control study. Eur Urol Focus. 2022;8(5):1433\u201340. https:\/\/doi.org\/10.1016\/j.euf.2021.10.009.","journal-title":"Eur Urol Focus"},{"issue":"3","key":"6441_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/SPV.0000000000000423","volume":"23","author":"AUGS Consensus Statement","year":"2017","unstructured":"AUGS Consensus Statement. Association of anticholinergic medication use and cognition in women with overactive bladder. Urogynecology. 2017;23(3):177. https:\/\/doi.org\/10.1097\/SPV.0000000000000423.","journal-title":"Urogynecology"},{"issue":"4","key":"6441_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s40266-21-00833-x","volume":"38","author":"S Chatterjee","year":"2021","unstructured":"Chatterjee S, Walker D, Kimura T, Aparasu RR. Prevalence and factors associated with cumulative anticholinergic burden among older long-stay nursing home residents with overactive bladder. Drugs Aging. 2021;38(4):311\u201326. https:\/\/doi.org\/10.1007\/s40266-21-00833-x.","journal-title":"Drugs Aging"},{"issue":"3","key":"6441_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","volume":"4","author":"M Boustani","year":"2008","unstructured":"Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311\u201320. https:\/\/doi.org\/10.2217\/1745509X.4.3.311.","journal-title":"Aging Health"},{"issue":"2","key":"6441_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0000000000000744","volume":"27","author":"BJ Linder","year":"2021","unstructured":"Linder BJ, Gebhart JB, Elliott DS, Van Houten HK, Sangaralingham LR, Habermann EB. National patterns of filled prescriptions and third-line treatment utilization for privately insured women with overactive bladder. Urogynecol. 2021;27(2):e261. https:\/\/doi.org\/10.1097\/SPV.0000000000000744.","journal-title":"Urogynecology"},{"issue":"3","key":"6441_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/nau.24880","volume":"41","author":"A Sripad","year":"2022","unstructured":"Sripad A, Raker C, Shireman T, Sung V. Overactive bladder medication prescription trends from 2014 to 2018. Neurourol Urodyn. 2022;41(3):806\u201312 https:\/\/doi.org\/10.1002\/nau.24880.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"6441_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.15074","volume":"6","author":"D Luchristt","year":"2023","unstructured":"Luchristt D, Bretschneider CE, Kenton K, Simon M, Brown O. Inequities in filled overactive bladder medication prescriptions in the US. JAMA Netw Open. 2023;6(5):e2315074. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.15074.","journal-title":"JAMA Netw Open"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06441-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-025-06441-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06441-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:52:41Z","timestamp":1784551961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-025-06441-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["6441"],"URL":"https:\/\/doi.org\/10.1007\/s00192-025-06441-2","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Financial Disclaimer\/Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was reviewed by the Northwestern University Institutional Review Board and was deemed not to be human subject research because all data collected were deidentified.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}